REG - Evoke PLC - Statement regarding media speculation

EvokeAnnouncement

Today 07:02

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260420:nRST0950Ba&default-theme=true

RNS Number : 0950B  Evoke PLC  20 April 2026

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

20 April 2026

evoke plc

("evoke" or the "Company")

Statement regarding media speculation

evoke notes the recent media speculation and confirms that it is in
discussions with Bally's Intralot S.A. ("Bally's Intralot") regarding a
possible offer for the entire issued and to be issued share capital of the
Company at a price of 50 pence per share (the "Proposal"). The Proposal is
expected to comprise an all-share combination with a partial cash alternative.

There can be no certainty that an offer will be made or as to the terms on
which any offer might be made.

The Board of evoke is evaluating the possible offer together with its
financial advisers, Morgan Stanley and Rothschild & Co.

evoke shareholders are advised not to take any action in relation to the
Proposal.

A further announcement will be made when appropriate.

Bally's Intralot has confirmed to the Company that it will, by no later than
5.00 p.m. (London time) on 18 May 2026, being 28 days after the date of this
announcement, either announce a firm intention to make an offer for the
Company or announce that it does not intend to make an offer. This deadline
can be extended with the consent of the Company.

Bally's Intralot has confirmed that any firm offer, if made, would be subject
to customary conditions and approvals and that it reserves the right to vary
the terms of any such offer, including the price, the form and mix of
consideration and the structure of the transaction.

This announcement has been made with the consent of the Bally's Intralot
Board.

The person responsible for arranging the release of this announcement on
behalf of the Company is Fredrik Ekdahl.

 

For further information, please contact:

evoke

Per Widerström, CEO

Sean Wilkins, CFO

James Finney, Director of IR

Tel: +44 (0) 800 029 3050

Media - Hudson Sandler

Alex Brennan / Hattie Dreyfus / Andy Richards

Tel: +44 (0) 20 7796 4133

Morgan Stanley

Laurence Hopkins

Ben Grindley

Paolo Della Rovere

Tel: +44 (0) 20 7425 8000

Rothschild & Co.

Daniel Ross

Edward Duckett

Ashley Gillard

Tel: +44 (0) 20 7280 5000

The City Code on Takeovers and Mergers

The City Code on Takeovers and Mergers (the "Code") does not apply to the
Company as it is registered in Gibraltar. As a result, a takeover offer for
the Company will not be regulated by the UK Panel on Takeovers and Mergers
(the "Panel"). The Company's articles of association contain certain
provisions requiring the Company to use its reasonable endeavours to apply the
rules of the Code to a takeover offer for the Company (except where not in the
best interest of the Company to do so), although these do not provide the full
protections afforded by the Code and the enforcement of such provisions is the
responsibility of the Company, not the Panel. Accordingly, shareholders of the
Company are reminded that the Panel does not have responsibility, in relation
to the Company, for ensuring compliance with the Code and is not able to
answer shareholders' questions in that regard.

Publication on website

A copy of this announcement will be available at www.evokeplc.com, by no later
than 12 noon (London time) on 21 April 2026. The content of the website
referred to in this announcement is not incorporated into and does not form
part of this announcement.

Number of shares in issue

As at the close of business on 17 April 2026 (being the business day prior to
the date of this announcement), evoke confirms that it had in issue
450,634,446 ordinary shares of GBP £0.005 each (excluding shares held in
treasury) with voting rights and admitted to trading on the main market of the
London Stock Exchange under the ISIN code GI000A0F6407.

Further information

This announcement is not intended to and does not constitute an offer to buy
or the solicitation of an offer to subscribe for or sell or an invitation to
purchase or subscribe for any securities or the solicitation of any vote in
any jurisdiction. The release, publication or distribution of this
announcement in whole or in part, directly or indirectly, in, into or from
certain jurisdictions may be restricted by law and therefore persons in such
jurisdictions should inform themselves about and observe such restrictions.

Morgan Stanley & Co. International plc ("Morgan Stanley"), which is
authorised by the Prudential Regulation Authority ("PRA") and regulated by the
PRA and the Financial Conduct Authority ("FCA") in the United Kingdom, is
acting exclusively for evoke and for no one else in connection with the
possible offer and neither Morgan Stanley nor any of its affiliates, nor their
respective directors, officers, employees or agents will be responsible to
anyone other than evoke for providing the protections afforded to its clients
or for providing advice in relation to the possible offer, the contents of
this announcement or any other matters referred to in this announcement.

N.M. Rothschild & Sons Limited ("Rothschild & Co"), which is
authorised and regulated by the Financial Conduct Authority in the United
Kingdom, is acting exclusively for evoke and for no one else in connection
with the subject matter of this announcement and will not be responsible to
anyone other than evoke for providing the protections afforded to its clients
or for providing advice in connection with the subject matter of this
announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  SPCKZGZDKGRGVZG



            Copyright 2019 Regulatory News Service, all rights reserved